SEC Form 4 · accession 0000899243-15-005466
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Geoffrey McDonough
Director
Period of report
Sep 24, 2015
Accepted (ET)
Sep 28, 2015 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $40.56 | Sep 24, 2015 | A | 24,000 | A | — | Sep 24, 2025 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The option vests in equal monthly installments over a three-year period beginning on September 24, 2015. All unvested options will vest effective upon the consummation of a change in control.